Top 10 ASX Dividend Stocks for Nov 2026 Download Free Report

1800-272-662
Shopping Cart 0
countryflagAU
Login

Home CompaniesVitasora Health Ltd

Vitasora Health Ltd

Healthcare Health Information Services
PortfolioPortfolio WatchlistWatchlist
Company price
0.012 AUD 0.00(0%)
Last update at 2026-11-10T23:00:00Z
VOLUME
35000
Market Cap
25.84M

Momentum Score

…

Vitasora Health Limited engages in the research, development, and commercialization of medical devices in Australia and the United States. The company offers wheezo device. It is also involved in the production of mobile health applications. In addition, the company provides solutions for managing chronic diseases, including cardiovascular, diabetes, chronic obstructive pulmonary disease, and obesity. The company was formerly known as Respiri Limited and changed its name to Vitasora Health Limited in April 2025. The company is headquartered in Melbourne, Australia.

Source: TradingView
The charts and visual representations are sourced from TradingView through embedded widgets. For any issues with chart display, please visit the TradingView website

Day Price Range
0.01
Low
0.01
High
52 Week Price Range
0.01
Low
0.03
High

Momentum Score

…
Loading momentum score…

A unique technical analysis driven score developed by Kalkine showing momentum in stock prices based on select technical indicators identified.

Score - Rating
>= 1 - Low / > 1 but < 2 - Below Average / > 2 but < 3 - Average / > 3 but < 4 - Above Average / > 4 - High
AI Summary

Public information on Vitasora Health Ltd (VHL.AU) is limited and available filings and disclosures do not provide a clear, verifiable description of the company's business activities. Because core operations and strategic plans are not well documented publicly, material long-term growth drivers cannot be reliably identified and investors may find the company difficult to evaluate.

The principal investment risk is the lack of transparent public disclosure, which increases governance, liquidity and execution uncertainty and makes assessment of financial health and regulatory exposure difficult.

Risk Score
High

Note: The summary and risk score provided above is created by AI and should not be construed as a recommendation of Kalkine.

Key Metrics*

Previous Close
0.01
Dividend Yield
-
Revenue TTM
4.84M
Revenue Per Share
0.00
Gross Profit TTM
4.26M
Debt / Equity
-
ROE
-70.26%
Net Debt
-3.06M
ROCE
-68.96%
Diluted EPS TTM
-0.01

Key Financials*

Income Statement

Balance Sheet

Change in Cash

Total Operating Cash

Dividends Paid

Breakdown 2026-06-30 2025-06-30 2024-06-30 2023-06-30 2022-06-30
Type yearly yearly yearly yearly yearly
Date 2026-06-30 2025-06-30 2024-06-30 2023-06-30 2022-06-30
Income before tax -11.16M -10.10M -7.13M -5.78M -6.62M
Net income -10.61M -10.11M -7.13M -5.78M -6.62M
Selling general administrative - 13.48M 6.94M 5.04M 4.68M
Gross profit -5.87M 3.68M 0.46M 0.00M -0.01M
Reconciled depreciation - 0.06M 0.06M 0.08M 0.08M
Ebit -11.17M - - - -
Ebitda -9.92M - - - -
Depreciation and amortization 1.25M - - - -
Operating income -11.17M -10.10M -7.65M -6.35M -7.07M
Other operating expenses 15.45M - - - -
Interest expense - - 0.07M 0.01M -
Tax provision - 0.00M 0.00M 0.00M 0.00M
Interest income - 0.00M - - -
Net interest income - - -0.07M -0.01M -
Income tax expense -0.55M - - - -
Total revenue 4.28M 3.71M 0.46M 0.07M 0.25M
Total operating expenses 5.30M 13.81M - - -
Cost of revenue 10.15M 0.03M - 0.07M 0.26M
Total other income expense net 0.02M 0.61M 0.58M 0.59M 0.45M
Net income from continuing ops - -10.11M -7.13M -5.78M -6.62M
Net income applicable to common shares - -10.11M - - -
Breakdown 2026-06-30 2025-06-30 2024-06-30 2023-06-30 2022-06-30
Type yearly yearly yearly yearly yearly
Date 2026-06-30 2025-06-30 2024-06-30 2023-06-30 2022-06-30
Total assets 18.84M 18.40M 6.19M 3.18M 4.21M
Intangible assets 4.57M 6.06M 0.08M - -
Other current assets 0.27M 0.23M 0.22M 1.42M 0.03M
Total liab 2.71M 3.74M 3.55M 2.35M 1.20M
Total stockholder equity 16.13M 14.67M 2.64M 0.83M 3.01M
Other current liab 0.79M 0.13M - 0.29M 0.33M
Common stock 176.31M - - - -
Capital stock - 162.92M 140.55M 132.10M 128.84M
Retained earnings -160.19M -150.77M -141.61M -138.05M -133.31M
Good will 6.63M 6.95M 1.96M - -
Cash 3.06M 0.39M 0.76M 0.15M 1.22M
Total current liabilities 2.64M 3.66M 3.43M 2.24M 1.20M
Net debt -3.06M - 0.41M - -
Short long term debt - - 1.18M - -
Total current assets 7.63M 5.34M 4.03M 3.00M 4.12M
Short term investments - 0.03M 0.03M - -
Net receivables 1.65M 1.51M 0.32M 0.00M -
Inventory 2.66M 2.88M 2.75M 1.23M 2.65M
Accounts payable 1.85M 2.80M 1.71M 1.51M 0.52M
Accumulated other comprehensive income 0.02M - - - -
Non current assets total 11.21M 13.07M 2.16M 0.18M 0.08M
Capital lease obligations - 0.06M 0.12M 0.15M 0.07M
Breakdown 2026-06-30 2025-06-30 2024-06-30 2023-06-30 2022-06-30
Type yearly yearly yearly yearly yearly
Date 2026-06-30 2025-06-30 2024-06-30 2023-06-30 2022-06-30
Investments - 1.13M -1.89M -0.02M -0.00M
Total cashflows from investing activities -0.49M 1.13M - - -
Total cash from financing activities 13.25M 7.66M 9.13M 3.46M 1.64M
Net income -10.61M -10.11M -7.13M -5.78M -4.55M
Change in cash 2.66M -0.37M 0.60M -1.05M -6.84M
Begin period cash flow 0.39M 0.76M 0.15M 1.22M 7.97M
End period cash flow 3.06M 0.39M 0.76M 0.15M 1.22M
Total cash from operating activities -10.00M -9.17M - - -
Issuance of capital stock - 7.92M 8.81M 3.65M 1.67M
Depreciation 1.25M - - - -
Other cashflows from investing activities - 1.13M - - -
Change to inventory 0.23M - - - -
Change to account receivables 0.38M - - - -
Sale purchase of stock - 7.92M -0.56M -0.39M -0.03M
Other cashflows from financing activities - -0.26M - - -
Capital expenditures 0.00M 0.00M 0.00M 0.02M 0.00M
Change in working capital -0.69M 0.62M - - -
Other non cash items 0.04M - - - -
Free cash flow -10.00M -9.17M -6.64M -4.51M -8.48M

Peer Comparison*

Sector: Healthcare Industry: Health Information Services

Stock Name
Change
(AUD)
Price
(AUD)
Trailing
PE (x)
Forward
PE (x)
Price Sales
TTM (x)
Price to Book Value (x)
Enterprise Value
to Revenue (x)
Enterprise Value
to EBITDA (x)
VHL
Vitasora Health Ltd		 -
-%		 0.01 - 0.93 5.34 1.60 5.31 -7.63
PME
Pro Medicus Ltd		 -4.52
2.18%		 202.79 81.98 106.38 83.13 43.70 74.38 95.34
4DX
4DMEDICAL Ltd		 -0.06
2.53%		 2.31 - - 205.57 8.53 170.03 -7.29
CGS
Cogstate Ltd		 0.12
3.30%		 3.76 33.80 27.86 9.59 6.95 6.35 19.27
AYA
ARTRYA Ltd		 -0.14
3.91%		 3.44 - - 20505.14 7.00 16927.51 0.33

Profile*

Vitasora Health Ltd

Vitasora Health Limited engages in the research, development, and commercialization of medical devices in Australia and the United States. The company offers wheezo device. It is also involved in the production of mobile health applications. In addition, the company provides solutions for managing chronic diseases, including cardiovascular, diabetes, chronic obstructive pulmonary disease, and obesity. The company was formerly known as Respiri Limited and changed its name to Vitasora Health Limited in April 2025. The company is headquartered in Melbourne, Australia.

432 St Kilda Road, Melbourne, VIC, Australia, 3004

61 3 9653 9160

https://vitasorahealth.com.au

Name Title Year Born
Mr. Nicholas Smedley Executive Chairman NA
Mr. Marjan Mikel B.Sc., M.A.I.C.D. CEO, MD & Executive Director NA
Mr. Peter Hildebrandt Chief Operations Officer NA
Mr. George Vlachodimitropoulos Chief Technology Officer NA
Dr. Samaneh Sarraf Shirazi Chief Research Officer NA
Mr. Theo Antonopoulos Chief Commercial Officer NA
Mr. William Sigsbee Head of US Operations & Chief Commercial Officer for the US market NA
Mr. Justin Mouchacca B.Bus (Acc), C.A., CA Joint Company Secretary NA
Ms. Nova Anne Taylor Joint Company Secretary NA
Prof. Noam Gavriely D.Sc., M.D. Medical & Scientific Advisor NA

Disclaimer - (*)This information, including any data, is sourced from Unicorn Data Services SAS, trading as EOD Historical Data (“EODHD”) on an ‘as is’ basis, using their API. We cannot guarantee the completeness or validity of the information and data provided on this page, as well as via the API. In some cases, the data may include analyst ratings or recommendations sourced through the EODHD API, which are intended solely for general information purposes.
This information does not consider your personal objectives, financial situation, or needs. Kalkine is not liable for any errors or omissions in the information provided or for any actions taken in reliance on it. You should seek advice from a financial adviser, stockbroker or other professional adviser (including taxation and legal advice) as necessary before acting on this information.

Kalkine

3 Mining Stock
Ideas Report

Download a free report with stock ideas and industry insights for general information.

Download Free Report Now → sector image

Top Stocks by Market Cap*

CU6
AUD 2.05
+23.49%
DMP
AUD 25.06
+12.93%
G6M
AUD 2.74
+10.93%
XRO
AUD 75.17
+6.08%
SGR
AUD 0.17
+6.06%
AXQ
AUD 3.07
-18.35%
BOE
AUD 1.50
-9.39%
GQG
AUD 0.71
-8.97%
MI6
AUD 0.81
-8.52%
ELV
AUD 3.73
-8.35%

Equity Sectors*

  • Basic Materials

    -3.09%

  • Communication Services

    +0.75%

  • Consumer Cyclical

    +0.43%

  • Consumer Defensive

    +0.12%

  • Energy

    -1.07%

  • Financial Services

    -0.02%

  • Healthcare

    +1.08%

  • Industrials

    -0.22%

  • Real Estate

    +0.61%

  • Technology

    -1.69%

  • Utilities

    -0.18%

Note: Daily price change (%) by sector excluding stocks with +/-90% daily price change. Companies above $500 million market capitalization are considered.

Support

Hi! How can we help you today?

Loading…